316 related articles for article (PubMed ID: 24642908)
1. Hyaluronic acid conjugates as vectors for the active targeting of drugs, genes and nanocomposites in cancer treatment.
Arpicco S; Milla P; Stella B; Dosio F
Molecules; 2014 Mar; 19(3):3193-230. PubMed ID: 24642908
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.
Gao M; Deng H; Zhang W
Curr Top Med Chem; 2021; 21(2):126-139. PubMed ID: 32962617
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid for anticancer drug and nucleic acid delivery.
Dosio F; Arpicco S; Stella B; Fattal E
Adv Drug Deliv Rev; 2016 Feb; 97():204-36. PubMed ID: 26592477
[TBL] [Abstract][Full Text] [Related]
4. [Hyaluronic acid-based carriers for tumor targeted delivery system].
Qiu LP; Long MM; Chen DW
Yao Xue Xue Bao; 2013 Sep; 48(9):1376-82. PubMed ID: 24358769
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-based conjugates for tumor-targeted drug delivery and imaging.
Saravanakumar G; Deepagan VG; Jayakumar R; Park JH
J Biomed Nanotechnol; 2014 Jan; 10(1):17-31. PubMed ID: 24724496
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy.
Wickens JM; Alsaab HO; Kesharwani P; Bhise K; Amin MCIM; Tekade RK; Gupta U; Iyer AK
Drug Discov Today; 2017 Apr; 22(4):665-680. PubMed ID: 28017836
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system.
Huang G; Huang H
J Control Release; 2018 May; 278():122-126. PubMed ID: 29649528
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic Acid-Conjugated Carbon Nanomaterials for Enhanced Tumour Targeting Ability.
Kearns O; Camisasca A; Giordani S
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011272
[TBL] [Abstract][Full Text] [Related]
9. Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging.
Lee JY; Chung SJ; Cho HJ; Kim DD
Biomaterials; 2016 Apr; 85():218-31. PubMed ID: 26874284
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured hyaluronic acid-based materials for active delivery to cancer.
Ossipov DA
Expert Opin Drug Deliv; 2010 Jun; 7(6):681-703. PubMed ID: 20367530
[TBL] [Abstract][Full Text] [Related]
12. Application of hyaluronic acid as carriers in drug delivery.
Huang G; Huang H
Drug Deliv; 2018 Nov; 25(1):766-772. PubMed ID: 29536778
[TBL] [Abstract][Full Text] [Related]
13. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
[TBL] [Abstract][Full Text] [Related]
14. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
[TBL] [Abstract][Full Text] [Related]
15. Advances in Hyaluronic Acid-Based Drug Delivery Systems.
Jiao Y; Pang X; Zhai G
Curr Drug Targets; 2016; 17(6):720-30. PubMed ID: 26028046
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
Sargazi A; Shiri F; Keikha S; Majd MH
Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
[TBL] [Abstract][Full Text] [Related]
17. An insight on hyaluronic acid in drug targeting and drug delivery.
Yadav AK; Mishra P; Agrawal GP
J Drug Target; 2008 Feb; 16(2):91-107. PubMed ID: 18274931
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery.
Luo Y; Wang X; Du D; Lin Y
Biomater Sci; 2015 Oct; 3(10):1386-94. PubMed ID: 26301700
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.
Choi KY; Saravanakumar G; Park JH; Park K
Colloids Surf B Biointerfaces; 2012 Nov; 99():82-94. PubMed ID: 22079699
[TBL] [Abstract][Full Text] [Related]
20. Targeting hyaluronic acid family for cancer chemoprevention and therapy.
Lokeshwar VB; Mirza S; Jordan A
Adv Cancer Res; 2014; 123():35-65. PubMed ID: 25081525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
